Phase I/II, Randomized, Observer-Blind, Placebo-Controlled, Single-Center Study of the Tolerability, Immunogenicity, and Efficacy of an Novartis' Investigational H. Pylori Vaccine in H. Pylori-Negative Adults.
Phase of Trial: Phase I/II
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Helicobacter pylori vaccine (Primary)
- Indications Helicobacter pylori infections
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 22 May 2012 Phase II results presented at Digestive Disease Week 2012.
- 19 May 2010 Actual patient number added as 63 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History